197 related articles for article (PubMed ID: 31206867)
1. Perturbation of the immune cells and prenatal neurogenesis by the triplication of the Erg gene in mouse models of Down syndrome.
Ishihara K; Shimizu R; Takata K; Kawashita E; Amano K; Shimohata A; Low D; Nabe T; Sago H; Alexander WS; Ginhoux F; Yamakawa K; Akiba S
Brain Pathol; 2020 Jan; 30(1):75-91. PubMed ID: 31206867
[TBL] [Abstract][Full Text] [Related]
2. [Is Neuron-Vascular Communication Disturbed in the Delayed Prenatal Brain Development of a Mouse Model of Down Syndrome?].
Ishihara K
Yakugaku Zasshi; 2021; 141(3):369-373. PubMed ID: 33642505
[TBL] [Abstract][Full Text] [Related]
3. The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome.
Guedj F; Pennings JL; Ferres MA; Graham LC; Wick HC; Miczek KA; Slonim DK; Bianchi DW
Am J Med Genet A; 2015 Sep; 167A(9):1993-2008. PubMed ID: 25975229
[TBL] [Abstract][Full Text] [Related]
4. Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome.
Aziz NM; Guedj F; Pennings JLA; Olmos-Serrano JL; Siegel A; Haydar TF; Bianchi DW
Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29716957
[TBL] [Abstract][Full Text] [Related]
5. Enlarged brain ventricles and impaired neurogenesis in the Ts1Cje and Ts2Cje mouse models of Down syndrome.
Ishihara K; Amano K; Takaki E; Shimohata A; Sago H; Epstein CJ; Yamakawa K
Cereb Cortex; 2010 May; 20(5):1131-43. PubMed ID: 19710359
[TBL] [Abstract][Full Text] [Related]
6. Functional transcriptome analysis of the postnatal brain of the Ts1Cje mouse model for Down syndrome reveals global disruption of interferon-related molecular networks.
Ling KH; Hewitt CA; Tan KL; Cheah PS; Vidyadaran S; Lai MI; Lee HC; Simpson K; Hyde L; Pritchard MA; Smyth GK; Thomas T; Scott HS
BMC Genomics; 2014 Jul; 15(1):624. PubMed ID: 25052193
[TBL] [Abstract][Full Text] [Related]
7. Gene and protein expression profiles of JAK-STAT signalling pathway in the developing brain of the Ts1Cje down syndrome mouse model.
Lee HC; Md Yusof HH; Leong MP; Zainal Abidin S; Seth EA; Hewitt CA; Vidyadaran S; Nordin N; Scott HS; Cheah PS; Ling KH
Int J Neurosci; 2019 Sep; 129(9):871-881. PubMed ID: 30775947
[No Abstract] [Full Text] [Related]
8. Novel insights from fetal and placental phenotyping in 3 mouse models of Down syndrome.
Adams AD; Hoffmann V; Koehly L; Guedj F; Bianchi DW
Am J Obstet Gynecol; 2021 Sep; 225(3):296.e1-296.e13. PubMed ID: 33766516
[TBL] [Abstract][Full Text] [Related]
9. Phenotype microarrays reveal metabolic dysregulations of neurospheres derived from embryonic Ts1Cje mouse model of Down syndrome.
Seth EA; Lee HC; Yusof HHBM; Nordin N; Cheah YK; Ho ETW; Ling KH; Cheah PS
PLoS One; 2020; 15(7):e0236826. PubMed ID: 32730314
[TBL] [Abstract][Full Text] [Related]
10. Comparative proteomic profiling reveals aberrant cell proliferation in the brain of embryonic Ts1Cje, a mouse model of Down syndrome.
Ishihara K; Kanai S; Sago H; Yamakawa K; Akiba S
Neuroscience; 2014 Dec; 281():1-15. PubMed ID: 25261685
[TBL] [Abstract][Full Text] [Related]
11. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
[TBL] [Abstract][Full Text] [Related]
12. [Molecular Mechanism Underlying Abnormal Differentiation of Neural Progenitor Cells in the Developing Down Syndrome Brain].
Kurabayashi N; Sanada K
Yakugaku Zasshi; 2017; 137(7):795-800. PubMed ID: 28674289
[TBL] [Abstract][Full Text] [Related]
13. Apigenin as a Candidate Prenatal Treatment for Trisomy 21: Effects in Human Amniocytes and the Ts1Cje Mouse Model.
Guedj F; Siegel AE; Pennings JLA; Alsebaa F; Massingham LJ; Tantravahi U; Bianchi DW
Am J Hum Genet; 2020 Nov; 107(5):911-931. PubMed ID: 33098770
[TBL] [Abstract][Full Text] [Related]
14. Increased lipid peroxidation in Down's syndrome mouse models.
Ishihara K; Amano K; Takaki E; Ebrahim AS; Shimohata A; Shibazaki N; Inoue I; Takaki M; Ueda Y; Sago H; Epstein CJ; Yamakawa K
J Neurochem; 2009 Sep; 110(6):1965-76. PubMed ID: 19645748
[TBL] [Abstract][Full Text] [Related]
15. [Identification of molecules with altered expression in the brain of mouse model for Down syndrome by comprehensive analyses].
Ishihara K
Yakugaku Zasshi; 2013; 133(9):989-94. PubMed ID: 23995807
[TBL] [Abstract][Full Text] [Related]
16. Gene network disruptions and neurogenesis defects in the adult Ts1Cje mouse model of Down syndrome.
Hewitt CA; Ling KH; Merson TD; Simpson KM; Ritchie ME; King SL; Pritchard MA; Smyth GK; Thomas T; Scott HS; Voss AK
PLoS One; 2010 Jul; 5(7):e11561. PubMed ID: 20661276
[TBL] [Abstract][Full Text] [Related]
17. Decrease in the T-box1 gene expression in embryonic brain and adult hippocampus of down syndrome mouse models.
Shimizu R; Ishihara K; Kawashita E; Sago H; Yamakawa K; Mizutani KI; Akiba S
Biochem Biophys Res Commun; 2021 Jan; 535():87-92. PubMed ID: 33348080
[TBL] [Abstract][Full Text] [Related]
18. Expression Profiling of Notch Signalling Pathway and Gamma-Secretase Activity in the Brain of Ts1Cje Mouse Model of Down Syndrome.
Yusof HH; Lee HC; Seth EA; Wu X; Hewitt CA; Scott HS; Cheah PS; Li YM; Chau DM; Ling KH
J Mol Neurosci; 2019 Apr; 67(4):632-642. PubMed ID: 30758748
[TBL] [Abstract][Full Text] [Related]
19. Genes Associated with Disturbed Cerebral Neurogenesis in the Embryonic Brain of Mouse Models of Down Syndrome.
Ishihara K
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680993
[TBL] [Abstract][Full Text] [Related]
20. Embryonic statistical analyses reveal 2 growth phenotypes in mouse models of Down syndrome.
Adams AD; Lin J; Bianchi DW; Bishop L; Sato T; Baxter LL; Hoffmann V; Koehly L; Guedj F
Am J Obstet Gynecol; 2024 Feb; 230(2):258.e1-258.e11. PubMed ID: 37544351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
